The AI4Leprosy initiative, a partnership involving the Novartis Foundation, Fiocruz, and Microsoft AI for Health, is utilising machine learning to analyse skin lesion photos for early leprosy detection. A study published in The Lancet Regional Health – Americas reported that this open-source tool achieves over 90% accuracy in identifying potential cases. Read the validation study at The Lancet.